Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2801 | 2556 | 35.9 | 64% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2180 | 2255 | NEUROTENSIN//SR 48692//NEUROTENSIN RECEPTOR |
30692 | 134 | INTESTINAL NERVE OF REMAK//REMAKS NERVE//BILATERAL INNERVATION |
33208 | 95 | 3RD MESSENGER//LEARNED HELPLESSNESS BEHAVIOR//MARKER ENZYME |
34379 | 72 | ALPHA TOCOPHEROL THERAPY//COMBINATION PATHOGENETIC THERAPY//GRP DEV MOL DIAGNOST IN IDUALIZED THER Y |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROTENSIN | Author keyword | 571 | 61% | 24% | 601 |
2 | SR 48692 | Author keyword | 181 | 100% | 2% | 47 |
3 | NEUROTENSIN RECEPTOR | Author keyword | 111 | 80% | 3% | 70 |
4 | NEUROMEDIN N | Author keyword | 86 | 90% | 1% | 37 |
5 | SR48692 | Author keyword | 72 | 93% | 1% | 27 |
6 | NEUROTENSIN RECEPTORS | Author keyword | 55 | 82% | 1% | 32 |
7 | NT69L | Author keyword | 48 | 100% | 1% | 17 |
8 | XENIN | Author keyword | 44 | 88% | 1% | 21 |
9 | PD149163 | Author keyword | 26 | 100% | 0% | 11 |
10 | NEUROTENSIN RECEPTOR ANTAGONIST | Author keyword | 24 | 91% | 0% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROTENSIN | 571 | 61% | 24% | 601 | Search NEUROTENSIN | Search NEUROTENSIN |
2 | SR 48692 | 181 | 100% | 2% | 47 | Search SR+48692 | Search SR+48692 |
3 | NEUROTENSIN RECEPTOR | 111 | 80% | 3% | 70 | Search NEUROTENSIN+RECEPTOR | Search NEUROTENSIN+RECEPTOR |
4 | NEUROMEDIN N | 86 | 90% | 1% | 37 | Search NEUROMEDIN+N | Search NEUROMEDIN+N |
5 | SR48692 | 72 | 93% | 1% | 27 | Search SR48692 | Search SR48692 |
6 | NEUROTENSIN RECEPTORS | 55 | 82% | 1% | 32 | Search NEUROTENSIN+RECEPTORS | Search NEUROTENSIN+RECEPTORS |
7 | NT69L | 48 | 100% | 1% | 17 | Search NT69L | Search NT69L |
8 | XENIN | 44 | 88% | 1% | 21 | Search XENIN | Search XENIN |
9 | PD149163 | 26 | 100% | 0% | 11 | Search PD149163 | Search PD149163 |
10 | NEUROTENSIN RECEPTOR ANTAGONIST | 24 | 91% | 0% | 10 | Search NEUROTENSIN+RECEPTOR+ANTAGONIST | Search NEUROTENSIN+RECEPTOR+ANTAGONIST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROMEDIN N | 179 | 79% | 4% | 114 |
2 | SR 48692 | 121 | 97% | 1% | 34 |
3 | IMMUNOREACTIVITY NTLI | 56 | 100% | 1% | 19 |
4 | ENDOGENOUS NEUROTENSIN | 45 | 94% | 1% | 16 |
5 | XENOPSIN | 31 | 92% | 0% | 12 |
6 | BLASTOMA CLONE N1E 115 | 30 | 68% | 1% | 26 |
7 | CLONE N1E 115 | 27 | 76% | 1% | 19 |
8 | PRONEUROTENSIN MESSENGER RNA | 26 | 100% | 0% | 11 |
9 | ADMINISTERED NEUROTENSIN | 23 | 100% | 0% | 10 |
10 | PEPTIDE XENIN | 23 | 100% | 0% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Neurotensin and neurotensin receptors | 1999 | 283 | 61 | 95% |
The Roles of Neurotensin and its Analogues in Pain | 2015 | 1 | 98 | 68% |
Neurotensin and neurotensin receptors: Characteristic, structure-activity relationship and pain modulation-A review | 2013 | 8 | 60 | 90% |
Neurotensin and dopamine interactions | 2001 | 134 | 330 | 76% |
Neurotensin: peptide for the next millennium | 2000 | 89 | 93 | 95% |
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers | 2011 | 21 | 108 | 79% |
Neurotensin: Role in psychiatric and neurological diseases | 2006 | 53 | 284 | 81% |
The role of neurotensin in central nervous system pathophysiology: What is the evidence? | 2006 | 52 | 319 | 79% |
THE NEUROBIOLOGY OF NEUROTENSIN - FOCUS ON NEUROTENSIN DOPAMINE INTERACTIONS | 1991 | 102 | 65 | 97% |
Neurotensin agonists - Potential in the treatment of schizophrenia | 2007 | 31 | 136 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INSERM U339 | 10 | 57% | 0.5% | 12 |
2 | MAYO CHEM CORE IL | 9 | 83% | 0.2% | 5 |
3 | MAYO PROT CORE IL | 8 | 100% | 0.2% | 5 |
4 | U339 | 4 | 26% | 0.5% | 14 |
5 | AUSTIN HOSP SURG | 2 | 67% | 0.1% | 2 |
6 | EMI 0350 | 2 | 67% | 0.1% | 2 |
7 | PHYSIOL GEN MUSCLES | 2 | 67% | 0.1% | 2 |
8 | CNS THER Y AREA | 2 | 50% | 0.1% | 3 |
9 | UNITE GYNECOL | 2 | 50% | 0.1% | 3 |
10 | MAYO FDN MED EDUC | 2 | 29% | 0.2% | 6 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000013078 | CHOLECYSTOKININ//L 365 260//GASTRIN |
2 | 0.0000010046 | SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE |
3 | 0.0000009578 | NUCLEUS ACCUMBENS//COCAINE//DOPAMINE |
4 | 0.0000009386 | SUBSTANCE P//TACHYKININ//TACHYKININS |
5 | 0.0000008652 | CD26//PROLYL OLIGOPEPTIDASE//PROLIDASE |
6 | 0.0000008514 | THYROTROPIN RELEASING HORMONE//TRH//TYR MIF 1 |
7 | 0.0000008166 | GALANIN//GALANIN RECEPTORS//GALANIN RECEPTOR |
8 | 0.0000007918 | PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP |
9 | 0.0000007490 | NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1 |
10 | 0.0000005778 | PROTEIN KINASE D//PROTEIN KINASE D PKD//MEF2C |